Deciphera Pharmaceuticals, Inc. Prepaid Expense and Other Assets, Current
Deciphera Pharmaceuticals, Inc. had Prepaid Expense and Other Assets, Current of $23.63 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2024-05-10
- 2024-03-31: Prepaid Expense and Other Assets, Current $23.63M.
- 2023-12-31: Prepaid Expense and Other Assets, Current $21.72M.
- 2023-09-30: Prepaid Expense and Other Assets, Current $23.85M.
- 2023-06-30: Prepaid Expense and Other Assets, Current $27.77M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2024-03-31 | $23.63M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $21.72M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $23.85M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $27.77M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $29.56M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $25.48M 10-K · filed 2024-02-07 |
| 2022-09-30 | $13.89M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $17.94M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $20.50M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $18.66M 10-K · filed 2023-02-07 |
| 2021-09-30 | $17.72M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $14.98M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $15.55M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $12.49M 10-K · filed 2022-02-08 |
| 2020-09-30 | $9.72M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $13.98M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $11.98M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $13.83M 10-K · filed 2021-02-09 |
| 2019-09-30 | $7.70M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $6.01M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $4.10M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $7.27M 10-K · filed 2020-03-09 |
| 2018-09-30 | $4.73M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $2.22M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $1.24M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $1.43M 10-K · filed 2019-03-14 |
| 2016-12-31 | $791.00K 10-K · filed 2018-03-28 |